Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/1999
05/19/1999EP0915842A1 Nitrate esters and their use for neurological conditions
05/19/1999EP0915834A1 Method and compositions for producing analgesia
05/19/1999EP0915830A1 Benzoylpropionic acid ester derivatives
05/19/1999EP0915701A1 Fast-dissolving galanthamine hydrobromide tablet
05/19/1999EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
05/19/1999EP0915653A1 Il-8 receptor antagonists
05/19/1999EP0915651A1 Il-8 receptor antagonists
05/19/1999EP0772440A4 Carbon monoxide dependent guanylyl cyclase modifiers
05/19/1999EP0752986B1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
05/19/1999EP0745596B1 Heteroaromatic oxazole compounds and use thereof
05/19/1999EP0730575B1 Novel carbamate compounds and processes for preparing the same
05/19/1999CN1217025A Processed polypeptides with IL-16 activity, process for preparing same and their use
05/19/1999CN1216991A Mesylate dihydrate salts of 5-(2-(4-(1,2-benzi sothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one
05/19/1999CN1216990A Mesylate trihydrate salt of 5-(2-(4-(1,2-benzi isothiazol-3-yl)-1-piperazinyl) ethyl)-6-chloro-1,3-dihydro-2(1H)-indol-2-one
05/19/1999CN1216986A Isoxazole derivatives
05/19/1999CN1216978A New vitamin-D derivatives with carbo- or heterocyclic substitutents at C-25, process for the prodn. intermediate products and their use for producing medicaments
05/19/1999CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them
05/19/1999CN1216762A 2-(arylphenyl) amino-imidazoline derivatives
05/18/1999US5905086 Remedy for anxiety neurosis
05/18/1999US5905084 5-HTIF -agonists effective in treating migraine
05/18/1999US5905080 Central nervous system, psychological, eating disorders; cognition activators, parkinson*s disease
05/18/1999US5905079 Antiepileptic, antiischemic agents; nervous system, and brain disorders
05/18/1999US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis
05/18/1999US5905069 Methods of decreasing or preventing pain using spicamycin or derivatives thereof
05/18/1999US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide
05/18/1999US5904923 Methods for preparing pharmaceutical compositions and using same to treat drug addiction
05/18/1999CA2179264C 6-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists
05/18/1999CA2161284C Novel o-arylmethyl n-thioacyl hydroxylamines, processes for their preparation and pharmaceutical compositions containing them
05/18/1999CA2158952C 2-substituted morpholine and thiomorpholine derivatives as gaba-b antagonists
05/18/1999CA2141436C Treatment of alzheimer's disease and modulation of immune system with delta-5-androstenes
05/14/1999WO1999023092A2 3-aminoalkylamino-2h-1,4-benzoxa(thia-)zines and pharmaceutical compositions containing them
05/14/1999WO1999023087A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
05/14/1999WO1999023075A1 Ortho-hydroxypyridinone derivatives as iron chelating and antioxidant agents
05/14/1999WO1999023073A1 Biphenyl derivatives as pharmaceuticals
05/14/1999WO1999023072A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999WO1999022758A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
05/14/1999WO1999022724A2 Extended release formulation containing venlafaxin
05/14/1999WO1999010338A3 Benzylidene- and cinnamylidene-anabaseines as neuronal nicotinic alpha-7 receptor agonists
05/14/1999WO1999001764A3 METHOD FOR DETERMINING GnRH RECEPTORS
05/14/1999WO1998053838A3 A soluble laminin receptor precursor and methods to inhibit its interactions
05/14/1999WO1998047917A9 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
05/14/1999WO1998033904A3 An antisense oligonucleotide preparation method
05/14/1999WO1997035539A3 Arylamino fused pyridines and pyrimidines
05/14/1999CA2681877A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/14/1999CA2308151A1 Biphenyl derivatives as pharmaceuticals
05/14/1999CA2307905A1 3-aminoalkylamino-2h-1,4-benzoxazines and 3-aminoalkylamino- 2h-1,4-benzothiazines: dopamine receptor subtype specific ligands
05/14/1999CA2307853A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
05/14/1999CA2305242A1 Extended release formulation
05/12/1999EP0915090A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease
05/12/1999EP0915088A1 D-Proline derivatives
05/12/1999EP0914614A1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrP?c AND PrP?sc
05/12/1999EP0914432A2 Secreted proteins and polynucleotides encoding them
05/12/1999EP0914428A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
05/12/1999EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2)
05/12/1999EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
05/12/1999EP0914332A1 Isoquinolines useful as analgesics
05/12/1999EP0914331A1 Neuroactive peptides
05/12/1999EP0914330A1 Novel compounds
05/12/1999EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
05/12/1999EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
05/12/1999EP0914145A1 Methods of controlling axonal growth
05/12/1999EP0914122A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
05/12/1999EP0914119A2 Solid oral dosage forms of valsartan
05/12/1999EP0914115A1 Methods of providing neuroprotection
05/12/1999EP0914104A1 Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
05/12/1999EP0751940B1 Sesquiterpenic derivatives
05/12/1999EP0735888A4 Purine compositions and methods for administration
05/12/1999EP0733067B1 N-terminally chemically modified protein compositions and methods
05/12/1999CN1043348C Asymmetrically substituted xanthines its producting process and its application as pharmaceutical composition
05/11/1999US5902823 Method for treating addiction using forskolin or extracts containing forskolin
05/11/1999US5902819 Triazole derivatives
05/11/1999US5902814 Treating psychotic disorder, intellectual disorders and anxiety, such as attention deficit hyperactivity disorder and schizophrenia
05/11/1999US5902813 Modulators of the benzodiaxepine receptor ot the gamma-butyric acid(a) receptor complex; anxiolytic, antiepileptic and -convulsant agents; sleep and memory disorders
05/11/1999US5902810 Pteridine derivatives as no synthase inhibitors
05/11/1999US5902807 Administering alpha-2-adrenoceptor antagonist selective for alpha-2c-adrenoceptor subtype
05/11/1999US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
05/06/1999WO1999022243A1 148 human secreted proteins
05/06/1999WO1999021886A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE β-AMYLOID PEPTIDE OR ITS PRECURSOR
05/06/1999WO1999021875A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
05/06/1999WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
05/06/1999WO1999021856A1 Aminomethyl-benzo[a]quinolizidine derivatives, preparation and therapeutic applications for neurodegenrative diseases
05/06/1999WO1999021854A1 Bis-quaternary ammonium derivatives as neuromuscular relaxants
05/06/1999WO1999021836A1 Substituted isoquinoline derivatives and their use as anticonvulsants
05/06/1999WO1999021834A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
05/06/1999WO1999021824A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
05/06/1999WO1999021617A2 Allosteric adenosine receptor modulators
05/06/1999WO1999021581A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
05/06/1999WO1999021574A2 Enhancement of morphogen activity
05/06/1999WO1999021565A1 Nutritional supplement for cerebral metabolic insufficiencies
05/06/1999WO1999021553A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999021552A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
05/06/1999WO1999021542A2 Methods for modulating macrophage proliferation using polyamine analogs
05/06/1999WO1999021540A2 Method of reducing craving in mammals
05/06/1999WO1999021539A1 Method for treating disease-related or drug-induced dyskinesias
05/06/1999WO1999021422A1 Treatment of schizophrenia with ampakines and neuroleptics
05/06/1999WO1999013054A3 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
05/06/1999WO1999012549A3 Controlled release microsphere delivery system
05/06/1999WO1999011252A3 N,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of pain
05/06/1999EP0913481A2 Staphylococcus aureus member of the DEAD-type ATP-dependent RNA helicases (dbpB)
05/06/1999EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof
1 ... 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 ... 1833